Skip to content

    The Experiment of the
    Future is Digital.

    Synthace's Digital Experiment Platform helps you get products to market sooner, make faster, more confident decisions, and get more from your R&D.

    You know how to improve your lab.
    But what about your experiments?

    The best lab equipment and lab software in the world can only get you so far in life science R&D. They won't help you make critical business decisions, and when everyone else is using them they certainly won't give you a competitive edge.

    The answer? Digital experiment software.

     An ELN or a LIMS can't model and improve the experiment itself, so we built something that does. Synthace is the world's first digital experiment platform for high-performance life science R&D teams to accelerate their scientific progress.

    We're working with leaders from 9 of the top 15 pharmaceutical companies to reach definitive insights at lower costs, build more robust R&D forecasts, and prioritize research budgets more effectively.

    Ready to find out how?

    Request a Demo

    2
    Labiotech.eu

    Artificial intelligence and experiments in 2023

    The buzz surrounding generative AI has reached fever pitch. Experiments have always been the foundation of our biological understanding. If we can bring them into the digital domain, their potential will be transformative.

    Read the article
    3
    Bioscience Today

    Defining the future of experiment design

    Currently digitilization of life science R&D is very fragmented, with experiment design using a range of platforms and scientific collaborations which are neither efficient nor cost-effective. Imagine then adding coding to the mix. There’s no need for coding with our operating platform… it’s as easy as dragging and dropping!

    Read the article
    1
    Drug Discovery World

    Automation, AI and advancing the adjacent possible

    Digital Experiment Platforms speed the discovery of new drug targets, of new potential molecules, and help front-line R&D scientists analyze large and complex multidimensional datasets more effectively.

    Read the article

    Can't wait? Get started today.

    Don't take our word for it

    “Using Synthace has changed the way we do experiments, but more interestingly the way we think and communicate.”

    Helena Peilot Sjögren | Principal Scientist, AstraZeneca

    “Synthace has enhanced the scientific questions we can explore. We’ve increased our experimental throughput by over tenfold. Their exceptional customer support and commitment to education have also been invaluable.”

    Keara Sutherland, Virica Biotech | Associate Scientist

    “Synthace allows us to make it routine for us to walk away from creating 24-48 constructs so our scientists can focus on other tasks”

    Karen Bunting | Director of Protein Sciences, Ipsen

    “Synthace allows us to think outside the box, and do things we couldn't do before.”

    André Raposo | Group Lead - Computer-Aided Biology (CAB) group at Oxford Biomedica